The prevalence of HIV infection in neonates, children, and adults in the US is such that the disability and morbidity caused by the AIDS Dementia Complex alone will have a significant clinical and social impact in the next decade. The occurrence of opportunistic infections, neoplasms, and HIV infection of cells in the brain are well documented. In contrast, little s known concerning the responses of brain cells (neurons and glia) to either the HIV infection or to the presence of factors secreted by lymphomyeloid cells infiltrating the brain. An understanding of these responses is crucial because treatment may be effective in eliminating the symptoms of AIDS peripheral to the brain may not deter the neurodegenerative processes that occur in the brain during AIDS. To develop this understanding, basic information about alterations in genetic expression in brain cells in response to AIDS must be collected, analyzed, and interpreted. The general hypothesis is that in AIDS brain there are alterations in the levels of specific glial and neuronal gene products that: i) stimulate gliosis; 2) are neurotrophic; and iii) result in suppression of immune responses. In analyzing these gene products, the focus will be on the most obvious brain cell response to AIDS, gliosis. Gliosis is a hallmark of neurodegeneration and is defined as the appearance of numerous astrocytes and microglia, both having reactive morphology. Reactive microglia are enlarged and have prominent processes. Reactive astrocytes are enlarged, have prominent processes, and are filled with glial fibrillary acidic protein, an astrocyte specific protein, and S100, a neurotrophic calcium binding protein. An increase in S100 has been suggested as a possible contributor to neuronal degenerating because of the neurotrophic effects of S100, i.e., neurons might be excessively stimulated by over production of a neurotrophic factor. It is proposed here that microglia-derived IL-1 stimulates astrogliosis in AIDS and that this stimulation includes elevated expression of S100, resulting in neuronal dysfunction and decreased synthesis of somatostatin and acetylcholine. In order to determine whether alterations in genetic expression in neurons parallels increased expression of S100, mRNA levels in two neuronal cell types that have been implicated in dementia, vis., those that synthesize somatostatin and acetylcholine, will be analyzed. In addition to its effects on astrocytes, microglia-derived IL-1 may, like macrophage-derived IL-1, induce release of adrenocorticotrophin that in turn causes release of adrenocorticosteroid (hydrocortisone), which is immunosuppressive. The increase in microglia-derived IL-1 in AIDS brain, reported here, may, therefore, exacerbate the immunodeficiency in AIDS as well as induce astrogliosis. To test the hypothesis, analysis will be done at the cellular level where specific cell types can be identified by immunohistochemistry and the levels of specific mRNAs relative to total polyadenylated mRNA levels assessed by the in situ hybridization in individual cells. Successful testing of the general hypothesis will provide basic information concerning the response of specific neuronal and glial cell populations known to be affected in dementing disorders. Such information is necessary for the development of effective strategies for treating the neurodegenerative processes in AIDS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
7R01NS027414-04
Application #
2266409
Study Section
Special Emphasis Panel (ARR (V1))
Project Start
1990-08-01
Project End
1995-07-31
Budget Start
1993-08-01
Budget End
1994-07-31
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Arkansas Children's Hospital Research Institute
Department
Type
DUNS #
City
Little Rock
State
AR
Country
United States
Zip Code
72202
Royston, M C; McKenzie, J E; Gentleman, S M et al. (1999) Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition. Neuropathol Appl Neurobiol 25:387-93
Sheng, J G; Mrak, R E; Griffin, W S (1998) Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol (Berl) 95:229-34
Griffin, W S; Sheng, J G; Mrak, R E (1998) Senescence-accelerated overexpression of S100beta in brain of SAMP6 mice. Neurobiol Aging 19:71-6
Griffin, W S; Sheng, J G; Royston, M C et al. (1998) Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol 8:65-72
Sheng, J G; Mrak, R E; Griffin, W S (1998) Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease. J Neuropathol Exp Neurol 57:323-8
Griffin, W S; Sheng, J G; McKenzie, J E et al. (1998) Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis. Neurobiol Aging 19:401-5
Sheng, J G; Griffin, W S; Royston, M C et al. (1998) Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease. Neuropathol Appl Neurobiol 24:278-83
Mrak, R E; Griffin, S T; Graham, D I (1997) Aging-associated changes in human brain. J Neuropathol Exp Neurol 56:1269-75
Mrak, R E; Griffin, W S (1997) The role of chronic self-propagating glial responses in neurodegeneration: implications for long-lived survivors of human immunodeficiency virus. J Neurovirol 3:241-6
Ito, K; Ishikawa, Y; Skinner, R D et al. (1997) Lesioning of the inferior olive using a ventral surgical approach. Characterization of temporal and spatial astrocytic responses at the lesion site and in cerebellum. Mol Chem Neuropathol 31:245-64

Showing the most recent 10 out of 20 publications